Form 4 for AGL agilon health, inc.
Accepted 2025-03-18 00:00:00 ET · period of report 2025-03-14 · accession 0001628280-25-013599 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-18 | 2025-03-14 | AGL | Venkatachaliah Girish | CTO | P - Purchase | — | +9,429 | 158.4K | +6% | — | |
| 2025-03-18 | 2025-03-14 | AGL | Venkatachaliah Girish | CTO | F - Tax | $4.05 | -3,311 | 155.1K | -2% | -$13.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-14 | P | A | 9,429 | — | 158,431 | D | — | — | (F2) The number of PSUs that vested was determined based on agilon health's predetermined Revenue and Adjusted EBITDA goals over a three-year period from January 1, 2022 through December 31, 2024. Total attainment achieved was 87%. (F1) This award was granted on April 14, 2022 and all remaining performance-based restricted stock units (PSUs) subject to the award vested on March 14, 2025. (F3) Each PSU represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of PSUs in shares of common stock on their scheduled vesting date. |
| 2 | Common | Common Stock | 2025-03-14 | F | D | 3,311 | $4.05 | 155,120 | D | — | — | (F4) Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of PSUs and does not represent a sale. (F5) Includes restricted stock units. |